Tag
Astonea Labs Limited
2 articles
Astonea Labs H1 FY26 Related Party Transactions
Astonea Labs discloses ₹3,204.06 lakh in related party transactions for H1 FY26 ended March 31, 2026, per SEBI Regulation 23(9).
Transactions include ₹6,033 lakh remuneration to MD Ashish Gulati and m
Astonea Labs IPO Fund Reallocation to Damaira Pharmaceuticals
Astonea Labs discloses a ₹6.25 crore reallocation of unutilized IPO funds for a strategic investment in Damaira Pharmaceuticals.
The deviation was approved by the board on 27-Feb-2026 and shareholders